Msafe Equipments IPO allotment status can be verified via the registrar's website starting July 18, 2023. The estimated ...

On the surface, the 2025 micro-cap IPO market was more active than in 2024. Deal volume increased, listings steadily ...

Last year was the third-strongest on record for global venture funding with a surprisingly strong year for IPOs and an uptick in startup M&A numbers, and industry insiders we spoke with expect 2026 ...

Immunology biotech Agomab Therapeutics and eye-focused SpyGlass Pharma have both unveiled their intentions to go public, in ...

Accretion Nutraveda's IPO opened on January 28 with poor investor interest, subscribed only 0.01 times. The company plans to ...

Initial public offerings (IPOs) rank among the most closely followed events in the stock market. They inject new opportunities, and often renewed excitement, into the trading landscape. As a result, ...

Despite a U.S. government shutdown that hit the “pause” button on new initial public offerings, the IPO market is expected to finish 2025 as it started, with a flurry of newly minted publicly traded ...

Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 to $17 per share. The California biotech announced its IPO intentions ...

Dubai-based serial entrepreneur and venture capitalist Alexander Rugaev introduces boutique advisory focused on small-cap and micro-cap IPOs and direct listings for AI, robotics and fintech founders.

Renaissance IPO ETF (IPO) is rated a buy, anticipating a surge in major IPOs through 2026 to fuel renewed investor interest. IPO’s portfolio is heavily growth-oriented, with 94% SMID-cap exposure and ...

NSE IPO Latest Update: According to sources cited by Singhvi, NSE is likely to file its draft red herring prospectus (DRHP) ...

Through mid-November, the returns of initial public offerings have slowed, and the Renaissance IPO Index stands at a gain of 5.1% year to date, lagging the S&P 500 (up 16.4% by market price over the ...